CIANCIOLO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 4.288
AS - Asia 3.563
EU - Europa 3.280
AF - Africa 268
SA - Sud America 186
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.594
Nazione #
US - Stati Uniti d'America 4.234
VN - Vietnam 1.093
SG - Singapore 1.024
CN - Cina 773
IT - Italia 716
GB - Regno Unito 682
DE - Germania 571
SE - Svezia 271
HK - Hong Kong 236
FR - Francia 183
UA - Ucraina 167
IN - India 162
FI - Finlandia 160
RU - Federazione Russa 137
BR - Brasile 124
IE - Irlanda 111
TG - Togo 95
NL - Olanda 87
ZA - Sudafrica 72
JP - Giappone 56
EE - Estonia 50
BG - Bulgaria 42
JO - Giordania 42
SC - Seychelles 38
BE - Belgio 35
CA - Canada 31
KR - Corea 26
AR - Argentina 23
BD - Bangladesh 22
CI - Costa d'Avorio 22
PH - Filippine 20
NG - Nigeria 18
TH - Thailandia 17
CH - Svizzera 14
IQ - Iraq 14
IR - Iran 14
EC - Ecuador 13
MX - Messico 13
PL - Polonia 11
TR - Turchia 11
TW - Taiwan 10
AT - Austria 9
CO - Colombia 9
ES - Italia 9
CL - Cile 7
PK - Pakistan 7
UZ - Uzbekistan 7
DZ - Algeria 6
ID - Indonesia 6
SA - Arabia Saudita 6
AU - Australia 5
GR - Grecia 5
KE - Kenya 4
NP - Nepal 4
PT - Portogallo 4
PY - Paraguay 4
RO - Romania 4
EG - Egitto 3
LT - Lituania 3
MA - Marocco 3
VE - Venezuela 3
AL - Albania 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
HN - Honduras 2
LB - Libano 2
MY - Malesia 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CG - Congo 1
ET - Etiopia 1
FJ - Figi 1
GH - Ghana 1
GL - Groenlandia 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TN - Tunisia 1
UG - Uganda 1
UY - Uruguay 1
Totale 11.594
Città #
Singapore 769
Southend 568
Ashburn 475
Fairfield 371
Chandler 354
Ann Arbor 287
Hong Kong 232
Munich 201
San Jose 200
Dong Ket 192
Wilmington 191
Ho Chi Minh City 186
Houston 183
Hanoi 176
Santa Clara 161
Woodbridge 161
Helsinki 144
Seattle 137
Princeton 129
Cambridge 120
Jacksonville 117
Beijing 116
Dublin 111
Lomé 95
Boardman 82
Nanjing 70
Bologna 65
Westminster 61
Padova 60
Lauterbourg 51
Los Angeles 50
Turin 47
Berlin 46
Tokyo 46
Council Bluffs 43
Milan 43
Amman 42
Frankfurt am Main 42
Sofia 40
Dearborn 35
Jinan 35
Brussels 34
Buffalo 32
New York 32
Florence 31
Changsha 29
Hefei 29
Rome 28
Shenyang 27
Bremen 26
Johannesburg 26
Dallas 25
São Paulo 24
Abidjan 22
Da Nang 22
Medford 22
Nanchang 22
Tianjin 21
Hebei 20
Mülheim 20
Saint Petersburg 20
Guangzhou 18
Haiphong 18
Falkenstein 17
Abeokuta 16
Falls Church 16
Phoenix 16
Redondo Beach 16
Redwood City 16
Hyderabad 15
London 15
Zhengzhou 15
Shanghai 14
Toronto 14
Hangzhou 12
Mahé 12
Mountain View 12
San Diego 12
Amsterdam 11
Brooklyn 10
Can Tho 10
Fuzhou 10
Orem 10
Pune 10
Seoul 10
Des Moines 9
Hải Dương 9
Jiaxing 9
Atlanta 8
Chicago 8
Leawood 8
Montreal 8
San Francisco 8
Guayaquil 7
Ningbo 7
Norwalk 7
Rio de Janeiro 7
Taiyuan 7
Tashkent 7
Turku 7
Totale 7.487
Nome #
La sindrome delle gambe senza riposo in dialisi. Ruolo dell'infiammazione cronica 486
Molecular Adsorbent Recirculating System (MARS) application in liver failure: Clinical and hemodepurative results in 22 patients 404
Multislice spiral computed tomography (MSCT) for coronary artery calcifications in hemodialysis patients 297
Accesso vascolare e infiammazione: fistola arterovenosa (FAV) vs protesi in PTFE vs cateteri venosi centrali a permanenza (TCC) 274
5-Methyltetrahydrofolate Administration Is Associated with Prolonged Survival and Reduced Inflammation in ESRD Patients 272
Cardiovascular Disease in Kidney Transplant Recipients: The Prognostic Value of Inflammatory Cytokine Genotypes. 268
Effects of unfractioned heparin and low-molecular-weight heparin on osteoprotegerin and RANKL plasma levels in haemodialysis patients. 258
A new mathematical model for profiled-HFR 251
A case of Paget's disease in hemodialysis. 237
Combined application of Hemodiafiltration and Profiler: short and mid-term clinical results in 16 patients. 226
PTFE Grafts Versus Tunneled Cuffed Catheters for Hemodialysis: Which Is the Second Choice When Arteriovenous Fistula Is Not Feasible? 225
Donor/recipient delta age: A possible risk for arterial stenosis in renal transplantation 220
Anti-neutrophil cytoplasmic autoantibody-associated vasculitis in the very elderly: a 90-year-old iron lady. 219
Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. 215
Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype? 215
Methylenetetrahydrofolate reductase, MTHFR, polymorphisms and predisposition to different multifactorial disorders 214
Comparison of Two Parathyroid Hormone Assays in Hemodialysis Patients 211
Coronary Calcifications in End-Stage Renal Disease Patients: A New Link between Osteoprotegerin, Diabetes and Body Mass Index? 207
Hypoacusia and chronic renal dysfunction: new etiopathogenetic prospective. 202
Impiego clinico del “Fegato Artificiale” MARS: effetti sulle citochine e sui fattori di crescita 201
Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients 199
Warfarin anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters thrombosis. 195
Clinical application of artificial liver support with the Molecular Adsorbent Recirculating System (MARS): impact on cytokines and growth factors 194
Thrombosis of Tunneled-Cuffed Hemodialysis Catheters: Treatment With High-Dose Urokinase Lock Therapy. 192
Eparina non frazionata vs eparina a basso peso molecolare: effetti sui livelli plasmatici di osteoprotegerina, RANKL e citochine infiammatorie in dialisi 189
Un nuovo modello matematico per la HFR profilata 188
EPC number and function is improved by VDRA treatment in hemodialysis patients 188
Impiego combinato HFR-Profiler: risultati clinici a breve-medio termine 185
Emerging drugs for chronic kidney disease 185
The cardiovascular burden of end-stage renal disease patients. 182
Effect of Vitamin D Receptor Activator Therapy on Vitamin D Receptor and Osteocalcin Expression in Circulating Endothelial Progenitor Cells of Hemodialysis Patients. 180
Functional Abnormalities and Thyroid Nodules in Patients with End-stage Renal Disease 179
Prevenzione della trombosi dei cateteri a permanenza per emodialisi: profilassi mediante anticoagulazione con warfarin 178
Effect of membrane permeability on survival of hemodialysis patients. 178
Polimorfismo del Vascular Endothelial Growth Factor e rischio cardiovascolare dopo trapianto renale 177
Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First? 174
Fibroblast Growth Factor 23: Mineral Metabolism and beyond 168
Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency. 162
Fattori di rischio genetici per la patologia cardiovascolare dopo trapianto di rene: ruolo dei polimorfismi delle citochine 161
Metabolic syndrome after kidney transplantation. 161
Jugular vein-mammary artery fistula after catheterism for hemodialysis: case report. 159
Genetic variability and cardiovascular risk in renal transplant recipients 156
Restenosis in Hemodialytic Fistulas and Chronic Kidney Disease-Associated Vascular Disease: Two Pathologies Driven by Metakaryotic Stem Cells. 155
VDR Expression on Circulating Endothelial Progenitor Cells in Dialysis Patients Is Modulated by 25(OH)D Serum Levels and Calcitriol Therapy. 153
Effects of unfractioned heparin and low-molecular-weight heparin on osteoprotegerin and RANKL plasma levels in hemodialysis patients 153
Factors determining cardiovascular disease progression after kidney transplant 153
Hemodiafiltration reduces mortality and prevents comorbidities? Technical innovations to improve hemodynamics and efficacy. [L'emodiafiltrazione riduce la mortalita' e previene le comorbidita'? Innovazioni tecniche per migliorare emodinamica ed efficacia.] 151
Tyrosine-Kinase Inhibitors for Treatment in Hemodialysis Patients on Kidney Transplant Waiting List. Comment on: Nakai et al 151
MARS EFFICIENCY IN 38 PATIENTS WITH LIVER FAILURE 149
L’espressione del VDR sui progenitori delle cellule endoteliali è modulata dai livelli sierici di vitamina D 25(OH) e dalla terapia con calcitriolo nei pazienti in dialisi 147
Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Allograft Function After Renal Transplantation: Evaluation of the Current Status and Future Insights 142
EXTRACORPOREAL DETOXIFICATION FOR HEPATIC FAILURE WITH MARS: DEPURATIVE EFFICIENCY AND CLINICAL RESULTS IN 38 PATIENTS 141
Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology 140
Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach 132
Vitamin D-FGF-23 axis in kidney transplant recipients 132
Role of the hemodialysis vascular access type in inflammation status and monocyte activation. 129
Klotho-FGF23, cardiovascular disease, and vascular calcification: black or white? 127
Importance of vascular calcification in kidney transplant recipients 125
Protonic pump inhibitors in kidney transplant patients: efficacy and safety 121
Vitamin D in Kidney Transplant Recipients: Mechanisms and Therapy 105
null 88
null 75
null 73
Totale 11.774
Categoria #
all - tutte 28.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021366 0 0 0 0 0 0 0 0 0 0 0 366
2021/20221.389 155 67 85 100 134 81 42 85 61 97 266 216
2022/20231.507 129 252 72 212 82 118 30 75 288 40 141 68
2023/2024436 35 49 30 70 36 87 16 25 17 26 20 25
2024/20251.748 79 216 123 100 245 131 178 107 80 120 66 303
2025/20263.280 272 192 230 181 422 228 358 143 784 273 102 95
Totale 11.774